MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.
Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.
Your Unread Messages in Family Medicine
See All >> Messages include industry-sponsored communications and special communications from MDLinx
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Outcome in MI patients with hyponatremia
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Melanoma Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
341 The minimal clinically important difference of six-minute walk in Asian older adults Full Text BMC Geriatrics, March 13, 2013 Review Article
342 The brain-in-motion study: effect of a 6-month aerobic exercise intervention on cerebrovascular regulation and cognitive function in older adults Full Text BMC Geriatrics, March 13, 2013 Clinical Article
343 A multifactorial interdisciplinary intervention reduces frailty in older people: randomized trial Full Text BMC Medicine, March 13, 2013 Clinical Article
344 Supportive-expressive and coping group teletherapies for HIV-infected older adults: A randomized clinical trial AIDS and Behavior, March 13, 2013 Clinical Article
345 Immunogenicity and safety of a booster dose of diphtheria, tetanus, acellular pertussis and inactivated poliomyelitis vaccine (Tdap-IPV; Repevax) administered concomitantly versus non-concomitantly with an influenza vaccine (Vaxigrip) to adults aged ≥60 years: An open-label, randomised trial Vaccine , March 13, 2013 Clinical Article
346 Perceived health among the medically hospitalized elderly: A one-year follow-up study Scandinavian Journal of Public Health, March 13, 2013 Review Article
347 Validation of a questionnaire for assessing fecal impaction in the elderly: impact of cognitive impairment, and using a proxy Full Text BMC Geriatrics, March 13, 2013 Clinical Article
348 Self-Management Intervention for Chronic Pain in Older Adults: A Randomised Controlled Trial Pain, March 12, 2013 Clinical Article
349 Clinical characteristics and treatment outcomes of tuberculosis in the elderly: a case control study Full Text BMC Infectious Diseases, March 12, 2013 Clinical Article
350 Nutritional Status Assessment of Institutionalized Elderly in Prague, Czech Republic Annals of Nutrition and Metabolism, March 12, 2013 Clinical Article
351 Relationship between employment status and obesity in a Korean elderly population, based on the 2007-2009 Korean National Health and Nutrition Examination Survey (KNHANES) Archives of Gerontology and Geriatrics, March 12, 2013 Clinical Article
352 A Randomized, Controlled Trial to determine the effect of a model of restorative home care on physical function and social support among older people Archives of Physical Medicine and Rehabilitation, March 12, 2013 Review Article
353 Improving a Measure of Mobility-Related Fatigue (The Mobility-Tiredness Scale) by Establishing Item Intensity Journal of the American Geriatrics Society, March 12, 2013
354 A Qualitative Evaluation of a Telemedicine-Enhanced Emergency Care Program for Older Adults Journal of the American Geriatrics Society, March 12, 2013 Clinical Article
355 Impact of joint contractures on functioning and social participation in older individuals -- development of a standard set (JointConFunctionSet): study protocol Full Text BMC Geriatrics, March 12, 2013 Review Article
356 Cognitive Processing Speed is Related to Fall Frequency in Older Adults with Multiple Sclerosis Archives of Physical Medicine and Rehabilitation, March 11, 2013 Clinical Article
357 Delirium, A Symptom of UTI in the Elderly: Fact or Fable? A Systematic Review Journal of the American Medical Directors Association, March 11, 2013 Review Article
358 Growing old with fibromyalgia: factors that predict physical function Nursing Research, March 11, 2013 Clinical Article
359 Brain responses to bladder filling in older women without urgency incontinence Neurourology and Urodynamics, March 11, 2013 Clinical Article
360 Correlates of prolonged television viewing time in older Japanese men and women Full Text BMC Public Health, March 11, 2013 Clinical Article
In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.
Read the article summaryResearchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.
Read the article summaryBased on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.
Read the article summaryIndexed Journals in Family Medicine: American Family Physician, Archives of Family Med, Annals of Family Med more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close